Generic dossier
Ferric carboxymaltose
50 mg iron/mL · Injection · Haematinic
Product data
- Strength
- 50 mg iron/mL
- Dosage form
- Injection
- Dosage-form group
- Injectable
- Therapeutic area
- Haematinic
- Market
- EU/US
- Status
- Dossier target · Jul 2027
- Development status
- 1-year stability and characterisation completed; pilot bio planned Nov 2026
- Portfolio
- Generic dossier
Note: Source lists the category as “Anti Hematinic agent”V-20
Start a conversation
Where does your programme stand?
Tell us the molecule, the dosage form and the market you are filing in. A programme lead will read it and reply with what we would do next.
Business enquiries: vasanthi@kmshc.com · +91 97898 75194V-23